WO2005004639A1 - 生酵母菌を成分とする液剤の製造方法及びその液剤 - Google Patents
生酵母菌を成分とする液剤の製造方法及びその液剤 Download PDFInfo
- Publication number
- WO2005004639A1 WO2005004639A1 PCT/JP2004/006243 JP2004006243W WO2005004639A1 WO 2005004639 A1 WO2005004639 A1 WO 2005004639A1 JP 2004006243 W JP2004006243 W JP 2004006243W WO 2005004639 A1 WO2005004639 A1 WO 2005004639A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pineapple
- water
- yeast
- live yeast
- juice
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Definitions
- the present invention relates to a health-purifying agent to be consumed by humans or a water-purifying agent to be poured into rivers, public water bodies, and the like, and particularly to a live yeast produced by mixing live yeast and pineapple enzyme water as a component.
- the present invention relates to a method for producing a liquid preparation and the liquid preparation.
- live yeast has been widely used as a fermentation material for bread production and the like.
- this live yeast is known to use nutrients contained in it to make nutrients, which helps maintain health and helps cure the disease.
- nucleic acids are produced in the liver It is said that this function is weakened after adulthood. Therefore, this live yeast has attracted attention for its ability to heal diseases and enhance immunity by supplementing the nutrients of its nucleic acids.
- the present invention has been made to solve the above-mentioned problems.
- the purpose of the present invention is to allow live yeast to be ingested alive by freezing and treating live yeast cells, thereby maximizing the effect of the nucleic acid and improving cell efficiency.
- Another object of the present invention is to provide a method for producing a liquid preparation containing a live yeast which can maintain freshness, and a liquid preparation thereof.
- the live yeast is frozen to form a lump thereof, and the live yeast lump is cut into a predetermined particle size and thawed with a force.
- a method of producing a liquid preparation containing live yeast as a component comprising mixing pineapple enzyme water diluted with water.
- the live yeast mass be frozen at a low temperature of -25 ° C or lower. It is preferable that the live yeast be thawed in a low temperature range of 0 ° C to 5 ° C or less.
- the live yeast mass is cut by a cutting machine to a particle size of about 1 mm to 3 mm.
- the pineapple is shredded, and the shredded pineapple is mixed with water to produce the nutnapul juice, and quinic acid and yeast are mixed with the pineapple juice. Then, heat treatment is performed, and the supernatant of the pineapple juice is collected and diluted with water to a specified concentration for production.
- pineapple is shredded, and the shredded pineapple is mixed with degassed water or deep water to produce nynapul juice.
- Cuenic acid and yeast are mixed with the pineapple juice, and the pineapple juice is mixed at 60 ° C. It is preferable that the pineapple juice is subjected to heat treatment with C, and the supernatant of the pineapple juice is collected and diluted with water for production.
- live yeast is frozen to form a lump, the live yeast lump is cut into a predetermined particle size, force-thawed, and pineapple is shredded.
- the shredded pineapple is mixed with water to produce pineapple juice, and the pineapple juice is mixed with citric acid and yeast, followed by heat treatment, and the supernatant of the pineapple juice is recovered.
- Pineapple enzyme water produced by diluting with water, and a liquid formulation comprising live yeast, which is made up of capa and mixed with a higher content of the live yeast than the pineapple enzyme water.
- a liquid formulation comprising live yeast, which is made up of capa and mixed with a higher content of the live yeast than the pineapple enzyme water.
- a sweetener such as sugar or honey to a mixture of the yeast with pineapple enzyme water.
- pineapple enzyme water contains a mixture of citrate water and yeast which promote a catalytic function of activating microorganisms
- this liquid agent is inactivated in contaminated water. Therefore, when this liquid agent is sprayed on the contaminated water, colonies (populations) of the living spheres of the organisms in the contaminated water are formed after a predetermined period, and the microorganisms can easily survive.
- These microorganisms take in enzymes themselves or release them from the body to perform decomposition reactions, decompose substances such as organic compounds, nitrogen oxides and sulfides, and purify water quality by reducing oxidized water. Can be done.
- FIG. 1 is a block diagram showing a method for producing a liquid preparation containing live yeast of the present invention as a component.
- live yeast such as live yeast is frozen to form a live yeast mass, and the live yeast mass is reduced to a predetermined particle size.
- This is a production method in which the raw yeast cells that have been cut and thawed are mixed with pineapple enzyme water.
- the use of live yeast in the present invention is due to the power of nucleic acids in large amounts.
- live yeast cells are usually stored at about 1 ° C to 5 ° C.
- 500 g of the live yeast mass is frozen at a low temperature of 25 ° C or less and solidified. This is because by cutting in the frozen state, it is possible to treat live yeast cells without dying them. In addition, freezing of live yeast can prevent yeast from being fermented, so that it can be consumed as a healthy food without feeling full in the abdomen even when humans drink it. .
- the frozen and solidified live yeast cell mass is cut by a cutting machine (slicer) into a particle size of about lmm to about 3mm. Using this cutter, the live yeast cells in a frozen state are repeatedly cut a plurality of times to further cut them. In the production method of the present invention, since the lump of live yeast becomes an ice-like lump, it can be easily cut by a cutting machine (slicer).
- the cut live yeast cells are diluted with 2 liters of degassed water or deep water to cool, freeze and solidify the force.
- the reason for using deaerated water or deep water rather than tap water containing chlorine is to increase the transparency.
- the frozen live yeast is cut.
- the cutting, thawing and freezing of live yeast by the above-mentioned cutting machine (slicer) is repeated only once when the amount is small or about 15 times when the amount is large.
- the cut pineapple is mixed with deflated water or deep water to produce pineapple juice.
- deflated water or deep water rather than tap water containing chlorine is to increase the transparency.
- Use 5 liters of degassed water for one pineapple about lkg.
- citrus acid about 30 g
- yeast about 2 g
- yeast mixed with the pineapple juice may be dry yeast or liquid yeast in addition to live yeast.
- One pineapple can also obtain about 7 liters of undiluted solution of health food or water purification agent containing live yeast as a component. Use this stock solution diluted 5,000 to 10,000 times. A sweetener such as sugar or honey is added to the enzyme water of the nutnapul in an amount of 3% by weight of the total amount. Next, about 0.5 g to 2 g of the live yeast produced as described above is mixed with the pineapple enzyme water to complete the production of a health food or a liquid preparation as a water purification agent.
- FIG. 2 is a component table of live yeast.
- Figure 3 is a composition table of pineapple enzyme water.
- the liquid preparation produced by such a production method is, for example, a liquid preparation having a high ratio of “live yeast” as shown in the composition table of FIG. 2 or a pineapple enzyme water as shown in the composition table of FIG.
- the mixing ratio can be changed variously like liquids.
- the effect can be maximized by ingesting the nucleic acid alive by cutting the live yeast. Freezing keeps the cells fresh.
- the effect can be sufficiently exerted by drinking 0.5 g to 2 g per day. In particular, it can exert effects on adult diseases such as anticancer action and diabetes.
- a person suffering from laryngeal cancer drank 0.5 g / day of the liquid preparation of the present invention “live yeast”. On the day, he was able to eat without any side effects of anticancer drugs. One month after drinking lg for 1 day, 90% of cancer cells disappeared in 2 months.
- a person suffering from lung cancer drank 2 g of the solution of the present invention "live yeast cells" per day.
- the effect on cancer has been shown in two to three weeks. After drinking for three months, the cancer was completely cured.
- a person suffering from a liver drank 0.5 g / day of the liquid preparation of the present invention "live yeast". After one month of drinking, the cancer was completely cured.
- Kidney cancer female in their 40s
- a person suffering from renal cancer drank 0.5 g of the liquid preparation of the present invention "live yeast cells" per day. After drinking for 2 months, the cancer was completely cured.
- a person with a blood sugar level of 480 mg Zdl and a struggling life of several years has taken the liquid preparation of the present invention, "live yeast", to a normal value on the third day, and drank for 1 month. There has been no recurrence of diabetes for the next four years.
- a person with a blood sugar level of 233 mgZdl drank 0.5 g / d as a result of drinking 0.5 g of the liquid preparation of the present invention “live yeast” once.
- the liquid preparation of the present invention can be used not only as a health food but also as a water quality purifying agent to be introduced into contaminated water such as rivers.
- the live yeast and pineapple enzyme water mixed in the liquid preparation of the present invention can promote the catalytic function of activating the microorganisms in the contaminated water. Therefore, when a small amount of the liquid agent of the present invention is added to contaminated water, colonies (populations) of living spheres of living organisms are formed in the contaminated water in about three months, and microorganisms can easily survive. These microorganisms can take in enzymes themselves or release them outside the body to carry out decomposition reactions, decompose harmful substances, etc., and purify water quality by reducing oxidized water.
- the nucleic acid of the liquid preparation of the present invention can promote the catalytic function.
- microorganisms circulate To survive and survive, plankton is necessary, and the silicon of the complex is essential for the generation of plankton. Iron is necessary for the action of microorganisms, and metal ions can suppress the action of hydrogen sulfate.
- the liquid preparation of the present invention is dropped on contaminated water such as rivers, lakes, marshes, dams, harbors, coastal seas, and other public water bodies and ponds, and the quality of the contaminated water is purified.
- the liquid agent of the present invention is dropped on contaminated water such as sewage or drainage discharged from a facility installed in a factory or a business place, and the quality of the contaminated water is purified.
- FIG. 4 is a table showing the growth of yeast in contaminated water (sludge).
- yeasts that can survive in the presence or absence of oxygen can be useful for the activity of other microorganisms in contaminated waters.
- This phenomenon can play a role in photosynthetic bacteria that cannot occur in polluted waters.
- the growth of photosynthetic bacteria when the liquid agent of the present invention was added to contaminated water as a water purification agent, when it was not added, or when it was added to sediment sludge, and when it was not added. are extremely different.
- the method of the present invention for producing a liquid preparation containing a live yeast as a component is characterized in that, if a mixture of pineapple enzyme, yeast which promotes a catalytic function for activating a microorganism and citrate is mixed, It is not limited to the kinatsupuru enzyme extracted from the ginseng. That is, if it is easy to extract and its cost is low, various enzymes such as ⁇ papain '' located in papaya, ⁇ cathepsin '' located in animal cells, and ⁇ phosphatase '' located in plant cells are used. It is possible to do.
- the drug is applied to the face, directly applied to the skin, or exposed to the eyes. Is also possible.
- the liquid preparation of the present invention is inexpensive for live yeast, and can be mass-produced at low cost by diluting and using it in combination with pineapple enzyme. You can make the most of the fruits. In particular, it can exert an effect on adult diseases such as anticancer action and diabetes.
- liquid agent of the present invention can also be used as a water purification agent, so that it can be used to protect water resources that are not polluted even when discharged into public waters such as rivers.
- FIG. 1 is a block diagram illustrating a method for producing a liquid preparation containing a live yeast of the present invention as a component.
- FIG. 2 is a component table of live yeast.
- FIG. 3 is a component table of pineapple enzyme water.
- FIG. 4 is a table showing the growth of yeast in contaminated water (sludge).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Emergency Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
- Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04732001A EP1645198A4 (en) | 2003-07-10 | 2004-05-10 | METHOD FOR PRODUCING LIQUID FORMULATION CONTAINING RAWHEAD AND LIQUID FORMULATION |
US10/563,148 US20060177543A1 (en) | 2003-07-10 | 2004-05-10 | Process for producing liquid formulation containing raw yeast and liquid formulation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003195333A JP3535151B1 (ja) | 2003-07-10 | 2003-07-10 | 生酵母菌を成分とする液剤の製造方法及びその液剤 |
JP2003-195333 | 2003-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005004639A1 true WO2005004639A1 (ja) | 2005-01-20 |
Family
ID=32821702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/006243 WO2005004639A1 (ja) | 2003-07-10 | 2004-05-10 | 生酵母菌を成分とする液剤の製造方法及びその液剤 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20060177543A1 (ja) |
EP (1) | EP1645198A4 (ja) |
JP (1) | JP3535151B1 (ja) |
KR (1) | KR100769871B1 (ja) |
CN (1) | CN100496298C (ja) |
WO (1) | WO2005004639A1 (ja) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006298878A (ja) * | 2005-04-25 | 2006-11-02 | Kyoto Life Science Kenkyusho:Kk | 抗癌剤障害予防剤 |
CN101485483B (zh) * | 2009-03-02 | 2012-07-25 | 宋庆利 | 酵母饮料及其制备方法 |
CN101570366B (zh) * | 2009-06-12 | 2012-05-30 | 北京金源化学集团有限公司 | 一种用于强化污水生物处理的复合物液剂 |
EP2563169B1 (en) * | 2010-04-27 | 2017-06-14 | Chr. Hansen A/S | Method for the preparation of a fermented beverage |
CN102060371B (zh) * | 2010-11-16 | 2012-05-30 | 广州市翰瑞环境科技股份有限公司 | 一种用于污水处理的复合材料 |
JP6810826B2 (ja) * | 2018-02-27 | 2021-01-06 | 株式会社カネカ | 凍結生イースト成形体及びその製造方法 |
FR3097102B1 (fr) * | 2019-06-13 | 2021-09-24 | Lesaffre & Cie | Bloc de levain vivant prêt à l’emploi |
CN112831424B (zh) * | 2019-11-25 | 2023-07-14 | 可克达拉安琪酵母有限公司 | 一种耐受畜禽饲料制粒的酵母颗粒及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS505568A (ja) * | 1973-05-16 | 1975-01-21 | ||
JPH03127972A (ja) * | 1989-10-12 | 1991-05-31 | Puranzu Board Souei:Kk | 活性タンパク質分解酵素を含む植物エキス発酵飲料の製法 |
JP2003102425A (ja) * | 2001-09-27 | 2003-04-08 | Kirin Brewery Co Ltd | 酵母懸濁液食品素材及び飲料 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4218481A (en) * | 1978-10-06 | 1980-08-19 | Standard Oil Company (Indiana) | Yeast autolysis process |
DE2853573A1 (de) * | 1978-12-12 | 1980-07-03 | Bayer Ag | Herstellung von n-substituierten derivaten des l-desoxynojirimycins |
ATE64956T1 (de) * | 1984-06-14 | 1991-07-15 | Ciba Geigy Ag | Verfahren zur herstellung von thrombininhibitoren. |
DE19835767A1 (de) * | 1998-08-07 | 2000-02-17 | Kulicke Werner Michael | Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae |
-
2003
- 2003-07-10 JP JP2003195333A patent/JP3535151B1/ja not_active Expired - Fee Related
-
2004
- 2004-05-10 EP EP04732001A patent/EP1645198A4/en not_active Withdrawn
- 2004-05-10 KR KR1020067000409A patent/KR100769871B1/ko not_active IP Right Cessation
- 2004-05-10 CN CNB2004800194853A patent/CN100496298C/zh not_active Expired - Fee Related
- 2004-05-10 US US10/563,148 patent/US20060177543A1/en not_active Abandoned
- 2004-05-10 WO PCT/JP2004/006243 patent/WO2005004639A1/ja not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS505568A (ja) * | 1973-05-16 | 1975-01-21 | ||
JPH03127972A (ja) * | 1989-10-12 | 1991-05-31 | Puranzu Board Souei:Kk | 活性タンパク質分解酵素を含む植物エキス発酵飲料の製法 |
JP2003102425A (ja) * | 2001-09-27 | 2003-04-08 | Kirin Brewery Co Ltd | 酵母懸濁液食品素材及び飲料 |
Non-Patent Citations (1)
Title |
---|
See also references of EP1645198A4 * |
Also Published As
Publication number | Publication date |
---|---|
CN100496298C (zh) | 2009-06-10 |
CN1819776A (zh) | 2006-08-16 |
EP1645198A1 (en) | 2006-04-12 |
US20060177543A1 (en) | 2006-08-10 |
JP3535151B1 (ja) | 2004-06-07 |
JP2006304601A (ja) | 2006-11-09 |
EP1645198A4 (en) | 2007-04-04 |
KR100769871B1 (ko) | 2007-10-24 |
KR20060030899A (ko) | 2006-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mujoriya et al. | A study on wheat grass and its nutritional value | |
US20120213756A1 (en) | Nutraceutical beverage | |
Walker | Fresh vegetable and fruit juices | |
JP3507347B2 (ja) | 腐植土抽出物質含有水性液 | |
JP5358030B2 (ja) | 還元パウダー及びその製造方法 | |
CN106579387A (zh) | 一种阿拉伯糖酵素组合物及制备方法 | |
CN104273629A (zh) | 一种蜂蜜醋饮料 | |
JP3535151B1 (ja) | 生酵母菌を成分とする液剤の製造方法及びその液剤 | |
KR100284821B1 (ko) | 건강음료 | |
JP2003325165A (ja) | デュナリエラの培養生産方法と該培養生産方法で得られたデュナリエラを主成分とするタラソテラピー用剤 | |
CN1302785C (zh) | 一种保健药物组合物及其制备方法和用途 | |
KR101253342B1 (ko) | 비타민을 함유하는 새로운 향미의 마른김 조성물과 그 제조방법 | |
CN101240243A (zh) | 淡水培育出系列功能保鲜新型钝顶螺旋藻和极大螺旋藻 | |
CN101467718A (zh) | 健康型口服剂及其制作工艺 | |
CN110585327A (zh) | 用于杀灭和抑制动物细小病毒的植物细胞酶解物的制备方法 | |
CN109463591A (zh) | 一种具有缓解疲劳作用的苏打水及其制备方法 | |
KR100550075B1 (ko) | 건강보조차 | |
KR20010008906A (ko) | 무음료 제조방법 | |
JP2000166583A (ja) | 枯草菌等が産生する無機物及びその酸塩と副産物及びその誘導体 | |
CN107183430A (zh) | 一种可增强食欲的滁菊饮料及其制备方法 | |
Bragg | Water, the shocking truth | |
JP2003159036A (ja) | 海藻飲料とその製造方法 | |
KR20170006795A (ko) | 안구건조증 및 골다공증에 효과가 있는 석결명 식초 및 이의 제조방법 및 그 복용방법 | |
CN106805126A (zh) | 绿豆癀制造方法 | |
JP2021171037A (ja) | 抗ウイルス機能を持つ清涼飲料水 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480019485.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004732001 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006177543 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10563148 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067000409 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004732001 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10563148 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |